One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II

被引：61

作者：

Koster, A

Meyer, O

Fischer, T

Kukucka, M

Krabatsch, T

Bauer, M

Kuppe, H

Hetzer, R

机构：

[1] Deutsch Herzzentrum Berlin, Dept Anaesthesiol, D-13353 Berlin, Germany

[2] Humboldt Univ, Blood Bank, Charite, Berlin, Germany

[3] Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany

来源：

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2001年 / 122卷 / 06期

关键词：

D O I：

10.1067/mtc.2001.118271

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1254 / 1255

页数：2

共 5 条

[1] Improved laboratory confirmation of heparin-induced thrombocytopenia type II - Time course of antibodies and combination of antigen and biologic assays [J].

Harenberg, J ;

Wang, LC ;

Hoffmann, U ;

Huhle, G ;

Feuring, M .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (03) :432-438

[2] Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban [J].

Koster, A ;

Kulucka, M ;

Bach, F ;

Meyer, O ;

Fischer, T ;

Mertzlufft, F ;

Loebe, M ;

Hetzer, R ;

Kuppe, H .

ANESTHESIOLOGY, 2001, 94 (02) :245-251

[3]

Mak KH, 1998, THROMB HAEMOSTASIS, V80, P989

[4] Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia [J].

Pötzsch, B ;

Klóvekorn, W ;

Madlener, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :515-515

[5]

Walenga JM, 1999, SEMIN THROMB HEMOST, V25, P1

← 1 →